I don't think the day traders have a clue about the advisory committee and Pfizer. It has nothing to do with SequestOx approval. ELTP longs are just looking at the NEXT drug for approval, which apparently, ELTP will piggyback on with a BETTER DRUG!
The FDA is trying to come to grips as to what ADT should mean at its minimum and you could hear the panel struggle with what is or isn't enough as to what is or isn't a "true" deterrence. I just hope this state of ambivalence on some of the discussants doesn't trigger the need for an advisory meeting that otherwise, would have not been scheduled. Only time will tell. I am paranoid by the way.
News 
Market Data 
Discover 
